Shares of Sorrento Therapeutics (SRNE) rose 6.99% to $8.91 at 11:21 EST on Wednesday, after three successive sessions in a row of gains. NASDAQ Composite (SRNE) is rising 0.52% to $14,574.81, following the last session’s upward trend. This seems, up to now, a somewhat up trend exchanging session today.
Sorrento Therapeutics’s last close was $8.33, 57.04% below its 52-week high of $19.39.
Today’s last reported volume for Sorrento Therapeutics is 3834246 which is 47.32% below its average volume of 7277695.
Sorrento Therapeutics’s Sales
Sorrento Therapeutics’s sales growth is 53.9% for the ongoing quarter and 56.4% for the next. The company’s growth estimates for the ongoing quarter and the next is 52.8% and 45.5%, respectively.
Sorrento Therapeutics’s Revenue
Year-on-year quarterly revenue growth grew by 84.6%, now sitting on 46.52M for the twelve trailing months.
Sorrento Therapeutics’s last week, last month’s, and last quarter’s current volatility was a positive 1.05%, a negative 0.34%, and a positive 3.82%, respectively.
Sorrento Therapeutics’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.14% (last week), 4.56% (last month), and 3.82% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Sorrento Therapeutics’s stock is considered to be oversold (<=20).
Sorrento Therapeutics’s Stock Yearly Top and Bottom Value
Sorrento Therapeutics’s stock is valued at $8.91 at 11:22 EST, way below its 52-week high of $19.39 and way higher than its 52-week low of $5.17.
Sorrento Therapeutics’s Moving Average
Sorrento Therapeutics’s value is higher than its 50-day moving average of $8.83 and under its 200-day moving average of $9.19.
More news about Sorrento Therapeutics (SRNE).